Search research articles
Contact Us
Filters
Showing results (141-150 of 177) with videos related to
Page
of 18
Sort By:
Journal for Immunotherapy of Cancer
|
March 11, 2021
CXCR6 deficiency impairs cancer vaccine efficacy and CD8<sup>+</sup> resident memory T-cell recruitment in head and neck and lung tumors
Soumaya Karaki, Charlotte Blanc, Thi Tran, et al.
Leukemia
|
January 8, 2021
A modular and controllable T cell therapy platform for acute myeloid leukemia
Mohamed-Reda Benmebarek, Bruno L Cadilha, Monika Herrmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 10, 2019
Bispecific Antibodies Enable Synthetic Agonistic Receptor-Transduced T Cells for Tumor Immunotherapy
Clara H Karches, Mohamed-Reda Benmebarek, Moritz L Schmidbauer, et al.
Blood Advances
|
December 1, 2025
FLT3-directed BiTE Molecules versus CAR T Cells in AML: Co-stimulatory Signals Mitigate T-Cell Exhaustion
Lisa Rohrbacher, Daniel Nixdorf, Helena Stadler, et al.
The New England Journal of Medicine
|
March 4, 2026
Blinatumomab in Combined Immune Thrombocytopenia and Antiphospholipid Syndrome
Adrian Gottschlich, Veit Bücklein, Karim El-Marouk, et al.
Nature Communications
|
June 26, 2020
Protease-activation using anti-idiotypic masks enables tumor specificity of a folate receptor 1-T cell bispecific antibody
Martina Geiger, Kay-Gunnar Stubenrauch, Johannes Sam, et al.
Cell Reports. Medicine
|
May 16, 2024
CD37 is a safe chimeric antigen receptor target to treat acute myeloid leukemia
Benjamin Caulier, Sandy Joaquina, Pascal Gelebart, et al.
Journal for Immunotherapy of Cancer
|
January 7, 2021
Skin dendritic cells in melanoma are key for successful checkpoint blockade therapy
Anastasia Prokopi, Christoph H Tripp, Bart Tummers, et al.
Blood Reviews
|
November 29, 2025
CARing about autoimmune disorders. Use of chimeric antigen receptor engineered T-cells in autoimmune diseases
Adrian-Bogdan Tigu, Madalina Nistor, Diana Gulei, et al.
Cancer Immunology, Immunotherapy : CII
|
October 2, 2024
PD-1 blockade does not improve efficacy of EpCAM-directed CAR T-cell in lung cancer brain metastasis
Jens Blobner, Laura Dengler, Constantin Eberle, et al.
Page
of 18
Search research articles
Search
Showing results (141-150 of 177) with videos related to
Sort By:
Page
of 18
Journal for Immunotherapy of Cancer
|
March 11, 2021
CXCR6 deficiency impairs cancer vaccine efficacy and CD8<sup>+</sup> resident memory T-cell recruitment in head and neck and lung tumors
Soumaya Karaki, Charlotte Blanc, Thi Tran, et al.
Leukemia
|
January 8, 2021
A modular and controllable T cell therapy platform for acute myeloid leukemia
Mohamed-Reda Benmebarek, Bruno L Cadilha, Monika Herrmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 10, 2019
Bispecific Antibodies Enable Synthetic Agonistic Receptor-Transduced T Cells for Tumor Immunotherapy
Clara H Karches, Mohamed-Reda Benmebarek, Moritz L Schmidbauer, et al.
Blood Advances
|
December 1, 2025
FLT3-directed BiTE Molecules versus CAR T Cells in AML: Co-stimulatory Signals Mitigate T-Cell Exhaustion
Lisa Rohrbacher, Daniel Nixdorf, Helena Stadler, et al.
The New England Journal of Medicine
|
March 4, 2026
Blinatumomab in Combined Immune Thrombocytopenia and Antiphospholipid Syndrome
Adrian Gottschlich, Veit Bücklein, Karim El-Marouk, et al.
Nature Communications
|
June 26, 2020
Protease-activation using anti-idiotypic masks enables tumor specificity of a folate receptor 1-T cell bispecific antibody
Martina Geiger, Kay-Gunnar Stubenrauch, Johannes Sam, et al.
Cell Reports. Medicine
|
May 16, 2024
CD37 is a safe chimeric antigen receptor target to treat acute myeloid leukemia
Benjamin Caulier, Sandy Joaquina, Pascal Gelebart, et al.
Journal for Immunotherapy of Cancer
|
January 7, 2021
Skin dendritic cells in melanoma are key for successful checkpoint blockade therapy
Anastasia Prokopi, Christoph H Tripp, Bart Tummers, et al.
Blood Reviews
|
November 29, 2025
CARing about autoimmune disorders. Use of chimeric antigen receptor engineered T-cells in autoimmune diseases
Adrian-Bogdan Tigu, Madalina Nistor, Diana Gulei, et al.
Cancer Immunology, Immunotherapy : CII
|
October 2, 2024
PD-1 blockade does not improve efficacy of EpCAM-directed CAR T-cell in lung cancer brain metastasis
Jens Blobner, Laura Dengler, Constantin Eberle, et al.
Page
of 18